CAREERS |E-NEWS SIGN UP | CONTACT US | HOME     




PEI Agriculture finds new high value specialty markets
Monday, December 28, 2009
The PEI BioAlliance is proud to support an announcement that the Governments of Canada and PEI are partnering together to invest more than $6 million towards construction of a local bio-refinery in Kensington, PEI. The investment will introduce new-to-Canada technology to process specialty oilseeds for the global market. A new 10,000 square foot facility with a bulk grain receiver, research lab and administration offices will be constructed in Kensington. Over the next five years this development is expected to create 19 full time positions and generate $5.4 million in annual farm gate receipts.  
Phyterra yeast plant for wine opens doors in Eastern PEI
Friday, November 27, 2009
November 27, 2009 - Another exciting expansion for the PEI bioscience sector was announced today in Kings County, PEI.
National Research Council, Omnia Foods Sign Licensing Agreement for Cholesterol-Reduction Technology
Saturday, September 26, 2009
September 25, 2009, Charlottetown, PE Government of Canada researchers at the National Research Council (NRC) have developed innovative technology to help lower bad cholesterol levels by combining natural botanical extracts. Read More HERE...(pdf)
PEI Celebrates National Biotechnology Week
Thursday, September 24, 2009
September 18, 2009, Charlottetown, PE PEI Premier Robert Ghiz has declared the week of September 18-25th, 2009 as Biotechnology Week in Prince Edward Island. Premier Ghiz spoke to a group of local and international bioscience companies, as well as other members of the PEI Bioscience Cluster at an International BioPartnering Mission held in Charlottetown recently. Read More HERE...(pdf)
Halifax Brain Repair Centre joins forces with Neurodyn Inc.
Wednesday, August 19, 2009
August 11, 2009, Charlottetown, PE The Halifax Brain Repair Centre (BRC) has announced that they have entered into a new partnership with PEI's Neurodyn Inc. for the early detection and treatment of neurological diseases. This is the first such agreement for the BRC with a private Canadian biotech company.


1 | 2 | 3 | 4 | 5 | 6 | Next > >